跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 98,394 条关于
“LAG-3/TCR Bispecific T cell Silencer”
全部
98,394
临床试验
64,008
药物
11,207
机构
1,953
资讯
21,226
去年
Novel Bispecific Antibody Shows Promise for Autoimmune Disease Treatment in Preclinical Studies
3个月前
Author Correction Issued for MAGE-A4/MAGE-A8-Targeted TCR-Based Bispecific T Cell Engager Study
去年
Medigene and EpimAb Partner to Develop Novel TCR-Guided T Cell Engagers for Solid Tumors
去年
LAG-3 Inhibitors Show Promise in Cancer Immunotherapy, Market Expected to Surge
去年
FDA Approves Tecelra, a TCR-T Cell Therapy, Transforming Solid Tumor Treatment for Synovial Sarcoma
去年
FS118, a LAG-3/PD-L1 Bispecific Antibody, Shows Modest Efficacy in Relapsed/Refractory DLBCL
10个月前
Captain T Cell Secures €20 Million to Advance Next-Generation TCR-T Therapies for Solid Tumors
去年
Medigene Advances TCR-T Therapies with FDA Clearance and Strategic Partnerships
9个月前
Pan Cancer T Secures €10 Million to Advance TCR-T Cell Therapy for Triple-Negative Breast Cancer
2年前
FDA Roundup: TCR T-Cell Therapy Approved, CAR-T REMS Modified, and Clinical Holds Lifted
第 1 页，共 2123 页
上一页
下一页
